Xoom
  • Home (current)
  • Covid-19 Advisory
  • About Us
    • Vision, Mission & Core Values
    • Medical Board
    • The Team
    • Our Authorised Partner Pharmacies
    • Our Awards
  • Our Services
    • For Pharmacy
    • For Corporates
    • For Men's Sexual Health - DOC2MEN
    • Vaccination
    • COVID-19 HOME CARE PLAN
    • Diabetes Management
    • Virtual HIV/STD Clinic
  • MEDIA CENTRE
    • PRESS RELEASE
    • MEDIA KIT
    • NEWSROOM
  • Health Tips
  • ePharmacyNew!
    • Malaysia

Newsroom

  • Home
  • Newsroom
  • [Tally Press] Does The Brand Of COVID-19 Vaccines Matter?

DOC2US, the first and only telemedicine provider in Malaysia in compliance with the Ministry of Health to provide digitally signed e-prescription services, released a series of infographics to help address the concerns on COVID-19, its vaccines, and related issues. Based on the questions received by its COVID-19 Task Force via the government’s integrated platform, MySejahtera app, one of the most frequently asked questions in recent months is “Does the brand of COVID-19 vaccines matter?”


So, does it matter?

Dr Ming-Lee Ng, Medical Director of DOC2US said, “Different brands of COVID-19 vaccines have varying efficacies and it gets complicated when different brands measure efficacy differently. Instead of getting into the nitty-gritty of each brand, we should focus on the ultimate goal in achieving herd immunity by having at least 80% of the adult population in Malaysia vaccinated.”

According to Our World In Data, only 2.5% of the Malaysian population is fully vaccinated as at 18 May 2021, lagging behind the global figure of 4.7%.

Dr Raymond Choy, Chief Executive Officer of DOC2US said, “We assembled our COVID-19 Task Force which is made up of professional doctors and healthcare professionals shortly prior to the Movement Control Order (MCO) 1.0 in March last year. It is a voluntary virtual health advisory service with the aim to help the public gain adequate information about the spread and the management of the Covid-19 pandemic and reduce patient-medical healthcare specialist contact. The public can ask our task force questions on COVID-19 and related matters via the MySejahtera App for free.”

FAQ

1) Does the brand of COVID-19 vaccines matter?

The short answer is: No, the brand does not matter. Follow this link for a more detailed answer.

Image Credits: DOC2US

2) “What if I suddenly don’t feel like receiving the vaccination on that day? Can I just ffk (stands for fong fei kei, it means ditching or stand up on an appointment in Cantonese)?”

Technically you can. Receiving a vaccination is a voluntary action, you won’t be criminalised for ditching your COVID-19 appointment. However, unless you have a valid reason, you SHOULDN’T miss your COVID-19 vaccination appointment. Here’s why.

Image Credits: DOC2US

3) How to report adverse effects following a COVID-19 vaccination?

Image Credits: DOC2US

 

4) Can you tell me more about blood clots & COVID-19 vaccines?

Authorities in certain countries speculated that AstraZeneca’s or Johnson & Johnson’s COVID-19 vaccines are linked to a few rare but serious blood clotting cases. To be fair, when we said that these two vaccines are linked to rare but serious blood clotting cases, we don’t mean that the vaccines cause the blood clots; it’s just that these two vaccines and certain blood clot cases seem to have some unclear connection, but it doesn’t imply causation. At this stage, scientists simply do not know enough to answer that.

Image Credits: DOC2US

5) Should pregnant women receive the COVID-19 vaccine?

At the moment, no study to date has specifically evaluated the COVID-19 vaccine in pregnant and lactating women. In other words, we don’t have enough data to inform us how safe the COVID-19 vaccine is in such a population. This DOES NOT mean that COVID-19 vaccine is unsafe for pregnant and breastfeeding women, it’s just that we don’t know its safety for sure. You can click here for more info.

Image Credits: DOC2US

6) Are more young people in Malaysia infected by COVID-19?

According to the analysis published by CodeBlue, although the elderly aged 65 years old and above still comprise 59.5% of the death cases; but for the first time ever, the death rates among young people (25 to 54 years old) exceeded those who are slightly older, i.e. aged 55 to 64 years old, from March 31 to May 4 2021. In other words, more and more younger people in Malaysia have been admitted into ICU or died of COVID-19. You can click here for more info.

Image Credits: DOC2US

7) I’m Covid-positive and currently under home quarantine. However, I have yet to receive a call from KKM. What should I do now?

Please refer to this link for more information.

Image Credits: DOC2US

If the public has any enquiries related to COVID-19, they can consult the COVID -19 Task Force for FREE through MySejahtera>Digital Health>VHA>DOC2US.

Tags :

  • covid19vaccine

Share :

Written by

DOC2US

Latest News

AI-Powered Drug Pricing Tool To Help GP Clinics Navigate Transparency, Itemised Billing

KUALA LUMPUR, May 26 — T...

May 26, 2025

Celebrating 2 Million Electronic Prescriptions Milestone at DOC2US!

Celebrating 2 Million Electron...

Dec 12, 2023

DOC2US, University of Malaya & Taylor’s University Achieve Milestone Publication in Sage Journals

DOC2US, University of Malaya &...

Nov 24, 2023

Haier Teams Up with DOC2US and AIA to Prioritise Employee Health

Haier Teams Up with DOC2US and...

Nov 23, 2023

DOC2US Backs Gentari's Employee Wellbeing Initiative

DOC2US Backs Gentari's Employe...

Nov 15, 2023

Citibank Collaborates With DOC2US for On-Site Flu Vaccination & Health Screening

Citibank Collaborates With DOC...

Nov 06, 2023

Introducing DOC2US, Your Trusted Online Doctor. With its name synonymous to “talk to us”, DOC2US is a mobile application that allows you to talk to a doctor or any healthcare professionals via text chat at any time and from anywhere.

USEFUL LINKS

  • Home
  • About Us
  • For Pharmacy
  • Health Tips
  • Feedback
  • Fun Facts
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms
  • Telemedicine Policy
  • Medicine e-Prescription SOP

SITEMAP

Copyright © 2025 HEYDOC INTERNATIONAL SDN. BHD. (1141230-T) - ALL RIGHTS RESERVED  |   Powered by etc web design